# Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Study · id `cardio:ct-nct01049919` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01049919](<https://clinicaltrials.gov/study/NCT01049919>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01049919

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 153 participants.

## Technical summary

Registry record NCT01049919. Randomized; double masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2016-06 (actual). Results posted on 2021-05-28.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 153 participants (enrolled count; ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Primary completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Completion: 2020-02 (actual) (ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Results first posted: 2021-05-28 (ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01049919, source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01049919-2021-05-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
- Acronym: MOBILE
- Condition: Critical Limb Ischemia
- Condition: Peripheral Arterial Disease
- Condition: Peripheral Vascular Disease
- Intervention (Device): Bone marrow concentration device
- Intervention (Procedure): Placebo procedure (sham)
- Lead sponsor: Zimmer Biomet
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: f16632290bb8fca2e77289e61fcaf36223f811a6fab7969bc4df9e09cfcb9059
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
